Effects of Highly Absorptive Curcumin on Impaired Glucose Tolerance

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2012
INTERVENTION: High‐absorption curcumin with DDS (Theracurmin, 1 capsule: 30 mg) at a fixed daily dose of 6 capsules/day. Placebo at a fixed daily dose of 6 capsules/day. CONDITION: IGT PRIMARY OUTCOME: HbA1c INCLUSION CRITERIA: Patients with impaired glucose tolerance or type 2 diabetes, in whom HbA1c values between 6.3 and <8.4% (No history of insulin treatment within 1 year before registration)
Epistemonikos ID: 3660de78c6727548575ea36a31009ac64d20ed37
First added on: Aug 22, 2024